| 2025-04-21 |
详情>>
内部人交易：
Bastone Bronwen等共交易17笔
|
| 2025-04-21 |
详情>>
股本变动：
变动后总股本12984.74万股
|
| 2025-03-20 |
股东大会：
将于2025-04-17召开股东大会
会议内容 ▼▲
- 1.To adopt the Agreement and Plan of Merger, dated as of January 10, 2025 (such agreement, as it may be amended from time to time, the “Merger Agreement”), by and among Enfusion, Enfusion Ltd. LLC (“Enfusion OpCo”), Clearwater Analytics Holdings, Inc. (“Clearwater”), Poseidon Acquirer, Inc. (“Acquirer”), Poseidon Merger Sub I, Inc. (“Merger Sub”) and Poseidon Merger Sub II, LLC (“Merger Sub II”), pursuant to which, upon the terms and subject to the conditions set forth in the Merger Agreement, (i) Merger Sub II will merge with and into Enfusion OpCo (the “LLC Merger”), with Enfusion OpCo surviving the LLC Merger as an indirect subsidiary of Clearwater, (ii) Merger Sub will merge with and into Enfusion (the “Merger”), with Enfusion surviving the Merger as a direct, wholly-owned subsidiary of Clearwater (the “Surviving Corporation”), and (iii) subject to the satisfaction of certain conditions set forth in the Merger Agreement prior to the effective time of the Merger, the Surviving Corporation will merge with and into Acquirer (the “Second Merger,” and, together with the Merger and LLC Merger, the “Mergers”), with Acquirer surviving the Second Merger as a direct, wholly-owned subsidiary of Clearwater, and to approve the Mergers (adoption of the Merger Agreement and approval of the Merger, the “Merger Agreement Proposal”);
2.To approve the adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes to approve the Merger Agreement Proposal (the “Adjournment Proposal”).
|
| 2025-03-03 |
详情>>
业绩披露：
2024年年报每股收益0.03美元,归母净利润282.30万美元,同比去年增长-53.15%
|
| 2024-11-04 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.03美元,归母净利润270.20万美元,同比去年增长-49.98%
|
| 2024-11-04 |
财报披露：
美东时间 2024-11-04 盘前发布财报
|
| 2024-09-21 |
复牌提示：
2024-09-20 13:45:02 停牌，复牌日期 2024-09-20 13:50:09
|
| 2024-08-06 |
详情>>
业绩披露：
2024年中报每股收益0.01美元,归母净利润128.70万美元,同比去年增长-63.99%
|
| 2024-05-09 |
详情>>
业绩披露：
2024年一季报每股收益-0.01美元,归母净利润-53.9万美元,同比去年增长-118.3%
|
| 2024-04-26 |
股东大会：
将于2024-06-13召开股东大会
会议内容 ▼▲
- 1.To elect Oleg Movchan and Jan R. Hauser as Class III Directors to serve until the 2027 annual meeting of stockholders, and until their respective successors are duly elected and qualified, subject to their earlier resignation or removal.
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.
3.To transact any other business that properly comes before the Annual Meeting (including any adjournments, continuations and postponements thereof).
|
| 2024-03-12 |
详情>>
业绩披露：
2021年年报每股收益-2.26美元,归母净利润-1.58亿美元,同比去年增长-3998.47%
|
| 2024-03-12 |
详情>>
业绩披露：
2023年年报每股收益0.07美元,归母净利润602.50万美元,同比去年增长178.72%
|
| 2023-11-07 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-0.11美元,归母净利润-814.8万美元,同比去年增长-169.93%
|
| 2023-11-07 |
详情>>
业绩披露：
2023年三季报(累计)每股收益0.06美元,归母净利润540.20万美元,同比去年增长166.30%
|
| 2023-08-08 |
详情>>
业绩披露：
2023年中报每股收益0.04美元,归母净利润357.40万美元,同比去年增长136.89%
|
| 2023-05-09 |
详情>>
业绩披露：
2023年一季报每股收益0.04美元,归母净利润294.50万美元,同比去年增长140.54%
|
| 2023-05-01 |
股东大会：
将于2023-06-16召开股东大会
会议内容 ▼▲
- 1.To elect Michael Spellacy, Kathleen Traynor DeRose and Roy Luo as Class II Directors to serve until the 2026 annual meeting of stockholders, and until their respective successors are duly elected and qualified, subject to their earlier resignation or removal;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023;
3.To transact any other business that properly comes before the Annual Meeting (including any adjournments, continuations and postponements thereof).
|
| 2023-03-10 |
详情>>
业绩披露：
2022年年报每股收益-0.1美元,归母净利润-765.4万美元,同比去年增长95.17%
|
| 2022-04-29 |
股东大会：
将于2022-06-16召开股东大会
会议内容 ▼▲
- 1.To elect Bradford E. Bernstein, Thomas Kim and Larry Leibowitz as Class I Directors to serve until the 2025 annual meeting of stockholders, and until their respective successors are duly elected and qualified, subject to their earlier resignation or removal;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022;
3.To transact any other business that properly comes before the Annual Meeting (including any adjournments, continuations and postponements thereof).
|